BriaCell Therapeutics Corp.

Healthcare · Biotechnology · Canada

Last price 3.03 USD (Oct 30, 2026, 2:35 PM EDT) · Market cap 26.48M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore Co...